Valueact Capital

Latest Articles

2017-04-alpha-stephen-taub-the-childrens-investment-fund-tci-christopher-hohn-large.jpg

Chris Hohn’s TCI Leads Activists in a Mixed First Quarter

Stephen Taub April 14, 2017

The Morning Brief: Top Hedge Fund Staff Looking at Big Bonuses

Stephen Taub November 17, 2016

The Morning Brief: Democratic Senators Target Activists

Stephen Taub March 21, 2016

Valeant’s Winners and Losers

Stephen Taub March 16, 2016

The Morning Brief: ValueAct’s Ubben to Join 21st Century Fox Board

Stephen Taub September 30, 2015

Good Guys: Jeffrey Ubben And the Value of Crowds

Danielle Beurteaux September 22, 2015

The Morning Brief: Valiant Capital Scrambles Toward Break-even

Stephen Taub June 18, 2015

Whitworth’s Relational Employs Activist Loophole in Manitowoc Play

Stephen Taub June 30, 2014

Trian, ValueAct, Third Point Up Strongly in Good Year for Activists

Stephen Taub October 8, 2013

What Are Jeff Ubben's Plans For Moody's

Stephen Taub July 21, 2011

Cephalon Inc.'s Provigil Narcolepsy Medication

ValueAct’s Ubben Benefits From Valeant Deal

Stephen Taub March 31, 2011

ValueAct's Rx for Drug Merger

Stephen Taub June 22, 2010

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.03 build:2025-12-12 Login